GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tempus AI Inc (NAS:TEM) » Definitions » Sloan Ratio %

TEM (Tempus AI) Sloan Ratio % : -41.72% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tempus AI Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Tempus AI's Sloan Ratio for the quarter that ended in Dec. 2024 was -41.72%.

Warning Sign:

When sloan ratio (-41.72)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Dec. 2024, Tempus AI has a Sloan Ratio of -41.72%, indicating earnings are more likely to be made up of accruals.


Tempus AI Sloan Ratio % Historical Data

The historical data trend for Tempus AI's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tempus AI Sloan Ratio % Chart

Tempus AI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sloan Ratio %
Get a 7-Day Free Trial 1.35 -4.80 -10.08 7.19 -41.72

Tempus AI Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.19 8.35 -48.18 -43.76 -41.72

Competitive Comparison of Tempus AI's Sloan Ratio %

For the Health Information Services subindustry, Tempus AI's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tempus AI's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tempus AI's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Tempus AI's Sloan Ratio % falls into.


;
;

Tempus AI Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Tempus AI's Sloan Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2024 )-Cash Flow from Operations (A: Dec. 2024 )
-Cash Flow from Investing (A: Dec. 2024 ))/Total Assets (A: Dec. 2024 )
=(-705.809--189.045
--130.392)/926.116
=-41.72%

Tempus AI's Sloan Ratio for the quarter that ended in Dec. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2024 )
=(-705.809--189.045
--130.392)/926.116
=-41.72%

Tempus AI's Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was -64.743 (Mar. 2024 ) + -552.212 (Jun. 2024 ) + -75.84 (Sep. 2024 ) + -13.014 (Dec. 2024 ) = $-705.8 Mil.
Tempus AI's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was -101.378 (Mar. 2024 ) + -97.08 (Jun. 2024 ) + 48.664 (Sep. 2024 ) + -39.251 (Dec. 2024 ) = $-189.0 Mil.
Tempus AI's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 was 16.99 (Mar. 2024 ) + -8.008 (Jun. 2024 ) + -131.412 (Sep. 2024 ) + -7.962 (Dec. 2024 ) = $-130.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tempus AI  (NAS:TEM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2024, Tempus AI has a Sloan Ratio of -41.72%, indicating earnings are more likely to be made up of accruals.


Tempus AI Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Tempus AI's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tempus AI Business Description

Traded in Other Exchanges
N/A
Address
600 West Chicago Avenue, Suite 510, Chicago, IL, USA, 60654
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.